Reactions of Several D-Gluco- and D-Galactopyranose Derivatives
J . Org. Chem., Vol. 63, No. 26, 1998 9633
mL) and extracted with CHCl3 (3 × 25 mL). The combined
organic layer was washed with cold water (1 × 25 mL), dried
over Na2SO4, and concentrated under reduced pressure. The
residue was crystallized from ethyl acetate/diethyl ether as a
5 mL), and the combined organic layer was dried (MgSO4),
filtered, and concentrated under reduced pressure. Purification
by flash column chromatography (silica gel, 25% EtOAc in
hexanes) provided pure tri-O-benzyl epoxyamide 13 (120 mg,
87%). Similarly, compound 13 (145 mg, 85%) was prepared
from epoxyamide 21 (100 mg, 0.26 mmol) according to the
white solid (3.2 g, 53% yield): [R]25 +19.0° (c 2.3, CHCl3); 1H
D
NMR (200 MHz, CDCl3) δ 7.50-7.20 (m, 10 H), 5.57 (s, 1 H),
5.29 (d, J ) 3.1 Hz, 1 H), 5.02-4.72 (m, 3 H), 4.40-4.25 (m, 1
H), 4.08 (dd, J ) 4.3, 9.8 Hz, 1 H), 3.92-3.41 (m, 3 H), 2.50 (d,
J ) 5.4 Hz, 1 H); 13C NMR (50.3 MHz, CDCl3) δ 138.3, 138.1,
137.3, 137.1, 129.0-126.0, 101.3, 101.2, 97.1, 92.9, 82.0, 81.4,
80.3, 78.3, 75.2, 74.9, 74.4, 72.2, 69.0, 68.6, 66.5, 62.7; Anal.
Calcd for C20H22O6: C, 67.03; H, 6.19; found: C, 67.52; H, 6.48.
2-O-Ben zyl-4,6-O-ben zylid en e-D-glu cop yr a n ose (14). To
a solution of 2-O-benzyl-D-glucose12 (4.9 g, 18.1 mmol) in DMF
(25 mL) was added benzaldehyde dimethyl acetal (6.0 mL, 40.0
mmol) and p-toluenesulfonic acid (35 mg, 0.18 mmol) at 50
°C. After 9 h, DMF was removed under reduced pressure and
the residue purified on column chromatography (silica gel, 10:
1:8 CHCl3:MeOH:hexanes). The obtained product was crystal-
lized from ethyl ether to obtain pure 14 (1.5 g, 23% yield, 1:1
mixture of R:â anomers) as a white solid: Rf ) 0.81 (silica gel,
procedure described above. [13]: [R]25 +4.5° (q 2.3, CHCl3);
D
1H NMR (200 MHz, CDCl3) δ 7.53-7.22 (m, 20 H), 5.53 (s, 1
H), 4.92-4.33 (m, 8 H), 4.19 (dd, J ) 1.2, 9.2 Hz, 1 H), 4.07
(dd, J ) 1.8, 6.1 Hz, 1 H), 3.97 (m, 1 H), 3.69 (t, J ) 10.4 Hz,
1 H), 3.62 (t, J ) 4.9 Hz, 1 H), 3.49-3.27 (m, 3 H), 2.98-2.81
(m, 2 H), 0.95 (t, J ) 6.7 Hz, 3 H), 0.78 (t, J ) 6.7 Hz, 3 H);
13C NMR (50.3 MHz, CDCl3) δ 166.7, 137.9, 137.7, 137.3,
128.6-125.9, 101.1, 79.0, 78.7, 76.8, 74.1, 72.4, 71.3, 69.4, 68.0,
54.8, 50.7, 41.1, 40.4, 14.1, 12.9; FAB HRMS (NBA/CsI) m/e
784.7091, M + Cs+ calcd for C40H45O7N 784.7079.
N,N-Dieth yl-2,3-an h ydr o-4-O-ben zyl-6,8-O-ben zyliden e-
D-er yt h r o-L-ga la cto a n d L-id o-oct on a m id es (15a a n d
15b). Epoxyamides 15a and 15b (1.35 g, 93%) were prepared
from 2-O-benzyl-4,6-O-benzylidene-D-glucopyranose (14) (1.1
g, 3.1 mmol) by treatment with N,N-diethylcarbamoylmethyl
dimethyl sulfonium (4.2 g, 23.96 mmol) in THF (50 mL)
according to the procedure described above for 12. Purification
by flash column chromatography (silica gel, 50% AcOEt in
hexanes) provided pure epoxyamide 15b (250 mg) and a 1:1
mixture of 15a :15b (1.1 g, total yield 93%) as colorless oils.
[15b]: [R]25D -3.8° (c 7.1, CHCl3); 1H NMR (200 MHz, CDCl3)
δ 7.54-7.24 (m, 10 H), 5.51 (s, 1 H), 4.90 and 4.63 (2d, 2 H),
4.28 (dd, J ) 4.3, 10.4 Hz, 1 H), 4.11 (m, 1 H), 4.05-3.00 (m,
12 H), 1.12 (q, J ) 6.7 Hz, 6 H); 13C NMR (50.3 MHz, CDCl3)
δ 166.4, 137.6, 137.5, 128.6-125.9, 100.7, 80.8, 80.1, 72.6, 70.8,
69.4, 60.7, 57.5, 50.6, 41.2, 40.6, 14.4, 12.7; FAB HRMS (NBA/
CsI) m/e 494.2147, M + Cs+ calcd for C26H33O7N 494.2155.
15a (fr om a m ixtu r e w ith 15b): 13C NMR (50.3 MHz,
CDCl3) δ 166.7, 137.7, 137.5, 128.7-125.8, 100.8, 81.4, 80.0,
72.2, 60.0, 57.7, 50.3, 41.2, 40.7, 14.4, 12.7.
N,N-Dieth yl-2,3-a n h yd r o-4,5,7-tr i-O-ben zyl-6,8-O-ben -
zylid en e-D-er yth r o-L-ga la cto-octon a m id e (13) fr om 15a .
A solution of 15a (90 mg, 0.19 mmol) in THF (2 mL) was
treated with NaH (27 mg, 0.70 mmol, in 60% mineral oil),
tetrabutylammonium bromide (11 mg, 0.03 mmol), and benzyl
bromide (0.04 mL, 0.27 mmol) at 0 °C according to the
procedure described above for 13 from 12. Purification by TLC
(silica gel, 25% EtOAc in hexanes) provided pure 13 (44 mg,
35%), the spectroscopic and physical properties of which were
identical to 13 obtained above.
1
10:1:2 HCCl3:MeOH:hexanes); H NMR (200 MHz, CDCl3) δ
7.60-7.22 (m, 10 H), 5.49 (s, 1 H), 5.22 (dd, J ) 3.5, 12.0 Hz,
0.5 H), 5.00-4.74 (m, 2.5 H), 4.40-4.18 (m, 1 H), 4.05 (dd, J
) 3.8, 8.8 Hz, 1 H), 3.84-3.22 (m, 4 H); 13C NMR (50.3 MHz,
CDCl3) δ 137.9, 137.3, 136.8, 136.7, 129.6-126.0, 101.8, 101.6,
97.3, 91.5, 82.6, 80.9, 80.2, 79.3, 73.1, 72.9, 70.1, 68.7, 68.4,
65.7, 62.0.
4,6-O-Ben zylid en e-2-d eoxy-D-glu cop yr a n ose (17). Com-
pound 17 was prepared from 2-desoxi-D-arabino-hexose14 (3.0
g, 18.3 mmol) by treatment with benzaldehyde dimethyl acetal
(9.0 mL, 60.0 mmol) and p-toluenesulfonic acid (68 mg, 0.36
mmol) according to the procedure described above for the
preparation of 14, obtaining pure 17 (2.1 g, 46%) as a white
solid: 1H NMR (200 MHz, CDCl3) δ 7.62-7.35 (m, 5 H), 5.56
(s, 0.5 H), 5.54 (s, 0.5 H), 5.34 (s, 0.5 H), 4.86 (m, 0.5 H), 4.35-
4.13 (m, 2 H), 4.09-3.94 (m, 1 H), 3.93-3.28 (m, 4 H), 2.85-
2.60 (m, 1 H), 2.40-2.15 (m, 1 H), 1.82-1.52 (m, 1 H); 13C NMR
(50.3 MHz, CDCl3) δ 137.2, 137.1, 129.1-126.2, 101.9, 101.8,
94.4, 92.4, 84.0, 83.7, 69.0, 68.6, 67.9, 66.3, 65.2, 62.6, 37.7,
36.5.
N,N-Dieth yl-2,3-an h ydr o-5-O-ben zyl-6,8-O-ben zyliden e-
D-er yth r o-L-ga la cto-octon a m id e (12). A solution of 3-O-
benzyl-4,6-O-benzylidene-D-glucopyranose (11) (1.0 g, 2.8 mmol)
in THF (40 mL) was cooled to 0 °C and then N,N-diethylsul-
furanylidene acetamide (1) was added dropwise (2.0 g, 11.4
mmol). The mixture was allowed to stir at room temperature
for 12 h. After this time, the reaction mixture was neutralized
with 0.1 N HCl and the solvents were concentrated. The crude
product was extracted with CHCl3 (3 × 100 mL) and the
combined organic layer was dried (Na2SO4), filtered, and
concentrated under reduced pressure. Purification by flash
column chromatography (silica gel, 10:1:8 HCCl3:MeOH:hex-
anes) provided pure epoxyamide 12 (0.7 g, 54% yield) as a
white solid. Recrystallization was performed from CHCl3/
Et2O: [R]25D +13.7° (c 1.8, CHCl3); 1H NMR (200 MHz, CDCl3)
δ 7.55-7.22 (m, 10 H), 5.48 (s, 1 H), 4.78 (s, 2 H), 4.29 (dd, J
) 4.3, 11.0 Hz, 1 H), 4.25-3.92 (m, 4 H), 3.70 (d, J ) 2.4 Hz,
1 H), 3.59 (dd, J ) 9.8, 10.4 Hz, 1 H), 3.54-3.23 (m, 6 H), 3.15
(d, J ) 5.4 Hz, 1 H), 1.11 (m, 6 H); 13C NMR (50.3 MHz, CDCl3)
δ 166.5, 137.8, 137.6, 128.8-126.1, 100.8, 81.1, 79.9, 74.7, 70.9,
69.3, 62.4, 58.4, 50.7, 41.4, 40.7, 14.4, 12.8; FAB HRMS (NBA/
NaI) m/e 494.2146, M + Na+ calcd for C26H33O7N 494.2155.
N,N-Dieth yl-2,3-a n h yd r o-4,5,7-tr i-O-ben zyl-6,8-O-ben -
zylid en e-D-er yth r o-L-ga la cto-octon a m id e (13). To a cooled
solution (0 °C) of epoxyamide 12 (100 mg, 0.21 mmol) in THF
(2 mL) was added NaH (32 mg, 0.80 mmol, 60% in mineral
oil). The reaction mixture was stirred at 0 °C for 30 min and
then tetrabutylammonium bromide (9 mg, 0.03 mmol) and
benzyl bromide (0.03 mL, 0.27 mmol) were sequentially added.
The resulting mixture was allowed to stir at 25 °C for 2 days.
After this time, MeOH (0.25 mL) was carefully added at 0 °C,
then ether (5 mL) and saturated aqueous NH4Cl solution (5
mL) were sequentially added and the organic layer was
separated. The aqueous phase was extracted with ether (2 ×
N,N-Diet h yl-2,3-a n h yd r o-5,7-d i-O-a cet yl-4-O-b en zyl-
6,8-O-b en zylid en e-D-er yth r o-L-ga la cto a n d L-id o-oct on -
a m id es (16a a n d 16b). Acetylation of a mixture of 15a and
15b (157 mg, 0.33 mmol) was accomplished with acetic
anhydride (0.64 mL, 6.66 mmol) in pyridine (1.3 mL) by the
same procedure described above for 7, to obtain, after purifica-
tion by flash column chromatography (silica gel, 20% EtOAc
in hexanes), pure 16b (21 mg) and a 1:1 mixture of 16a :16b
(104 mg, 75% overall).
[16b]: [R]25 -5.2° (c 1.2, CHCl3); 1H NMR (200 MHz,
D
CDCl3) δ 7.45-7.23 (m, 10 H), 5.35 (dd, J ) 1.8 Hz, 1 H), 5.33
(s, 1 H), 4.89-4.54 (m, 3 H), 4.54 (dd, J ) 4.9, 10.4 Hz, 1 H),
4.37 (m, 1 H), 4.16 (dd, J ) 2.5, 9.8 Hz, 1 H), 3.74 (dd, J ) 6.7,
9.2 Hz, 1 H), 3.57 (t, J ) 10.4 Hz, 1 H), 3.55-3.24 (m, 6 H),
2.08 (s, 3 H), 2.03 (s, 3 H), 1.15-1.10 (m, 6 H); 13C NMR (50.3
MHz, CDCl3) δ 169.6, 169.8, 165.3, 136.8, 128.9-125.8, 101.1,
76.5, 75.1, 72.9, 68.2, 67.8, 61.5, 57.9, 50.7, 41.2, 40.5, 20.5,
14.6, 12.6; FAB HRMS (NBA/CsI) m/e 688.1543, M + Cs+ calcd
for C30H37O9N 688.1523. 16a (fr om a m ixtu r e w ith 16b): 1H
NMR (200 MHz, CDCl3) δ 7.51-7.21 (m, 10 H), 5.53 (s, 1 H),
5.21 (dd, J ) 1.8 Hz, 1 H), 4.96-4.36 (m, 4 H), 4.54 (m, 1 H),
4.24-3.20 (m, 8 H), 2.07 (s, 3 H), 2.03 (s, 3 H), 1.24-1.07 (m,
6 H); 13C NMR (50.3 MHz, CDCl3) δ 170.0, 165.6, 163.7, 129.0-
125.9, 101.2, 75.8, 72.3, 71.4, 70.3, 69.2, 61.7, 56.2, 49.3, 41.2,
40.5, 20.5, 14.4, 12.6.
N,N-Dieth yl-2,3-a n h yd r o-4-d eoxy-6,8-O-ben zylid en e-D-
glycer o-D-id o a n d D-ga la cto-octon a m id es (18a a n d 18b).
Epoxyamides 18a and 18b (1.11 g, 69%, 1:1.6 mixture) were
prepared from 17 (1.1 g, 4.3 mmol) by treatment with N,N-